A Phase I, Combined Study of the Safety, Tolerability, and Pharmacokinetics of SZV-1287 in Healthy Male Volunteers After Single Ascending and Multiple Ascending Oral Doses for 14 Days

2024-519485-50-00 Protocol SZV-1287-0020 Human pharmacology (Phase I) - First administration to humans Authorised, recruiting

Start 25 Nov 2024 · Status Authorised, recruiting · 1 EU/EEA countries · 1 sites · Protocol SZV-1287-0020

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Authorised, recruiting
Participants planned 68
Countries 1
Sites 1

neuropathic pain

Key facts

Sponsor
University Of Pecs
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male
Therapeutic area
Diseases [C] - Nervous System Diseases [C10]
Trial duration
25 Nov 2024 → ongoing
Decision date (initial)
2024-11-25
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-519485-50-00
EudraCT number
2021-001804-13

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

neuropathic pain

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

University Of Pecs

Sponsor organisation
University Of Pecs
Address
Vasvari Pal Utca 4
City
Pecs
Postcode
7622
Country
Hungary

Scientific contact point

Organisation
University Of Pecs
Contact name
Zsuzsanna Helyes

Public contact point

Organisation
University Of Pecs
Contact name
Zsuzsanna Helyes

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Hungary Authorised, recruiting 68 1
Rest of world 0

Investigational sites

Hungary

1 site · Authorised, recruiting
DRC Kft.
Phase I, Gyogy ter 2., 8230, Balatonfured

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Hungary 2024-11-25

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-11-06 Hungary Acceptable with conditions
2024-11-25
2024-11-25
2 SUBSTANTIAL MODIFICATION SM-2 2025-01-14 Hungary Acceptable
2025-01-15
2025-01-15
3 SUBSTANTIAL MODIFICATION SM-3 2025-01-27 Hungary Acceptable
2025-03-17
2025-04-16